Gelteq Limited (GELS) vs Sunshine Biopharma, Inc. (SBFM)

Gelteq Limited and Sunshine Biopharma, Inc. are both Drug Manufacturers Specialty & Generic companies. Gelteq Limited is the larger, with a market value of $5.9M against $3.3M — 1.8× the size. Across the 9 metrics below, Gelteq Limited leads on 6 and Sunshine Biopharma, Inc. on 3.

Valuation

Metric GELS SBFM Drug Manufacturers Specialty & Generic median
P/E — n/m 20.14
P/S — 0.03 2.25
P/B n/m 0.04 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 2.48 12.29
EV/Sales n/m (0.34) 2.56
Earnings yield — (1,208.33%) (2.99%)
Free cash flow yield 0.00% (482.76%) 0.00%

Profitability

Metric GELS SBFM Drug Manufacturers Specialty & Generic median
Gross margin — 30.30% 53.94%
Operating margin — (16.65%) 0.00%
Net margin — (16.50%) 0.00%
Free cash flow margin 0.00% (15.66%) 0.00%
Return on equity 0.00% (21.93%) (0.40%)
Return on assets 0.00% (17.78%) (3.32%)
Return on invested capital 0.00% (26.67%) 0.00%

Growth

Metric GELS SBFM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (2.74%) 10.01%
EPS growth (last fiscal year) (62.07%) 80.33% —
Revenue growth, 5-year CAGR — 247.74% 6.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GELS SBFM Drug Manufacturers Specialty & Generic median
Debt to equity 0.36 0.00 0.05
Current ratio 0.09 5.46 2.31
Net debt to EBITDA (0.91) 2.20 0.85

Dividend

Metric GELS SBFM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — 0.00 0.00

Size

Metric GELS SBFM Drug Manufacturers Specialty & Generic median
Market cap 5.89m 3.25m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack